logo

Publications

Frontiers in Immunology
October 2023

The emerging role of oral microbiota in oral cancer initiation, progression and stemness

Partha Jyoti Saikia, Lekhika Pathak, Shirsajit Mitra, Bikul Das

https://doi.org/10.3389/fimmu.2023.1198269

Frontiers in Immunology
September 2022

Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense

Seema Bhuyan, Bidisha Pal, Lekhika Pathak, Partha Jyoti Saikia, Shirsajit Mitra, Sukanya Gayan, Reza Bayat Mokhtari, Hong Li, Chilakamarti V Ramana, Debabrat Baishya, Bikul Das

https://doi.org/10.3389/fimmu.2022.933329

American Journal of Pathology
July 2021

Coronavirus Activates an Altruistic Stem Cell-Mediated Defense Mechanism that Reactivates Dormant Tuberculosis: Implications in Coronavirus Disease 2019 Pandemic

Pathak L, Gayan S, Pal B, Talukdar J, Bhuyan S, Sorra S, Yeger H, Baishya D, Das B*

https://doi.org/10.1016/j.ajpath.2021.03.011

Frontiers in Immunology
21 January 2021

Initiation of Post-Primary Tuberculosis of the Lungs: Exploring the Secret Role of Bone Marrow Derived Stem Cells

Pathak L, Das B*

https://doi.org/10.3389/fimmu.2020.594572

European Journal of Cancer
November 2003

In vitro cytoprotective activity of squalene in a bone marrow versus neuroblastoma model: its implication in cancer chemotherapy

Das B, Yeger H, Freedman M, Koren G, Baruchel S

https://doi.org/10.1016/j.ejca.2003.07.002

Neoplasia
October 2008

Squalene selectively protects mouse bone marrow progenitor against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth

Das B, Antoon R, Tsuchida R, Lotfi S, Morozova O, Farhat W, Malkin D, Koren G, Yeger H, Baruchel S

https://doi.org/10.1593/neo.08466

Cancer Res
15 August 2005

A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activate protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma

Das B, Yeger H, Tsuchida R, Torkin R, Gee MF, Thorner PS, Shibuya M, Malkin D, Baruchel S

https://doi.org/10.1158/0008-5472.CAN-04-4575

Oncogene
10 March 2008

Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling

Tsuchida R, Das B*, Yeger H, Koren G, Shibuya M, Thorner PS, Baruchel S, Malkin D

https://doi.org/10.1038/onc.2008.38

Stem Cells
08 May 2008

Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction

Das B*, Tsuchida R, Koren G, Malkin D, Baruchel S, Yeger H

https://doi.org/10.1634/stemcells.2007-0724

British Journal of Haematology
18 April 2012

A rare fraction of drug resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumorigenic potential

Lee C G, Das B, Lin L T, Grimes C, Zhang X, Lavezzi T, Huang L, Cole J, Yau L, Li L

https://doi.org/10.1111/j.1365-2141.2012.09123.x

Stem Cells
24 July 2012

HIF-2alpha suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells

Das B*, Bayat-Mokhtari R, Tsui M, Lotfi S, Tsuchida R, Felsher DW, Herman Yeger

https://doi.org/10.1002/stem.1142

American Journal of Pathology
16 October 2014

Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment

Beamer G, Major S, Das B, Campos-Neto A

https://doi.org/10.1016/j.ajpath.2014.08.024

American Journal of Pathology
08 June 2015

Preclinical and clinical evidences of the Mycobacterium tuberculosis persistence in the hypoxic niche of bone marrow mesenchymal stem cells after therapy

Garhain J, Bhuyan S, Kalita D, Pulu I, Das B*, Bhatnagar R

https://doi.org/10.1016/j.ajpath.2015.03.028

Science Translational Medicine
30 January 2013

CD271+ bone marrow mesenchymal stem cells provide a protective niche for dormant Mycobacterium Tuberculosis

Das B*, Kashino SS, Pulu I, Kalita D, Swami V, Yeger H, Felsher DW, Campos-Neto A

https://doi.org/10.1126/scitranslmed.3004912

BMC Cancer
30 August 2019

Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane

Bayat-Mokhtari R, Baluch N, Morgatskaya E, Kumar S, Sparaneo A, Muscarella LA, Zhao S, Cheng HL, Das B, Yeger H

https://doi.org/10.1186/s12885-019-6018-1

mSystems
6 August 2019

The oral mouse microbiome promotes tumorigenesis in oral squamous cell carcinoma

Stashenko P, Yost S, Choi Y, Danciu T, Chen T, Yoganathan S, Kressirer C, Ruiz-Tourrelia M, Das B, Frias-Lopez J

https://doi.org/10.1128/msystems.00323-19

Cancer Research
15 August 2019

MYC regulates the HIF-2alpha stemness pathway via Nanog and Sox2 to maintain self-renewal in cancer stem cells versus non-stem cancer cells

Das B*, Pal Bidisha, Bhuyan R, Li H, Sarma A, Gayan S, Talkudar J, Sandhya S, Bhuyan S, Gogoi G, Gouw AM, Baishya D, Gotlib JR, Kataki AC, Felsher DW

https://doi.org/10.1158/0008-5472.CAN-18-2847

logo

KAVIKRISHNA LABORATORY

कविकृष्ण प्रयोगशाला

About
Research
Academic Programmes
Centers